Login / Signup

Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern.

Nicholas P PinkhoverKerriann M PontbriandKelli P FletcherEduardo SanchezKenneth OkelloLiam M GarveyAlex PumKurvin LiGabriel DeOliveiraTeddie ProctorJelena D M FeenstraOcéane SorelManoj GandhiJared R Auclair
Published in: Microbiology spectrum (2024)
The results presented in our manuscript demonstrate how the value of simplistic and reliable molecular assays coupled with the core scientific principle of standardization can be overlooked by the charm of more sophisticated assays and instrumentation. This effect can often be amplified during tumultuous public health events, such as the COVID-19 pandemic. By adapting standardized PCR mutation panels to detect prominently circulating SARS-CoV-2 variants, we were able to better assess the potential health impacts of rising positivity rates and transmission clusters within the Northeastern University population. While several literature publications utilizing genotyping PCR and NGS have a similar scope to ours, many investigations lack sufficiently standardized genotyping PCR and NGS bioinformatics inclusionary/exclusionary criteria for SARS-CoV-2 variant identification. Finally, the economic benefits of standardized PCR mutation panels would allow for global implementation of biosurveillance, rather than reserving biosurveillance to more economically developed nations.
Keyphrases